Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Zinc Citrate Oral Capsule

Phase 2

EEndeavor Health

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[2][1]

Indication

Overactive Bladder (OAB)Recruiting

Overactive Bladder (OAB)Phase 2

Recruiting

Timeline

Expected Milestones

Q4 2026

Phase 2Recruiting

Overactive Bladder (OAB)

NCT07405554

Clinical

Trials by Indication[1]

Overactive Bladder (OAB)1 trial

Effect of Zinc Supplementation on Botulinum Toxin for Overactive Bladder: A Randomized, Double-Blind, Placebo-Controlled Trial

Recruiting·EEndeavor Health·Phase 2·NCT07405554·72 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Zinc Citrate Oral Capsule. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Zinc Citrate Oral Capsule. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Endeavor Health company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Phase 2[1]
Company: EEndeavor Health

Related News